Call our 24 hours, seven days a week helpline at 800.272.3900
Lecanemab is the second FDA-approved treatment that addresses the underlying biology of Alzheimer's and changes the course of the disease in a meaningful way for people in the early stages.
The Illinois Chapter's areas of service span 87 counties in Illinois, including Bloomington, Chicago, Joliet, Peoria, Quincy, Rockford, Springfield and Southern Illinois. Since 1980, the Association has provided reliable information and care consultation; created supportive services for families; increased funding for dementia research; and influenced public policy changes across the state.